Kaneka Corporation

4118.T
Specialty Chemicals
2026/08/21 Updated
Market Cap: $2.3B (¥368.2B)
Stock Price: $38.56 (¥6,131)
Exchange Rate: 1 USD = ¥158.98

Kaneka: Q1 Fiscal 2027 Financial Summary

Announces the Q1 results for the fiscal year ending March 2027. Highlights include year-over-year comparisons for net sales, operating income, ordinary income, and net income attributable to owners of the parent. The document includes a breakdown of net sales by segment, assets and liabilities composition, and outlook sections.

Importance:
Page Updated: August 13, 2026
IR Disclosure Date: August 13, 2026

Key Figures

  • Net Sales: 223,025 million yen
  • Operating Income: 14,944 million yen
  • Ordinary Income: 13,750 million yen

AI要約

Section Heading

Overview of business performance: despite the uncertain global economy, our group aims to increase net sales and expand profits across segments. Quarterly net sales are by segment, with four segments: Material Solutions Unit, Quality Life Solutions Unit, Health Care Solutions Unit, and Nutrition Solutions Unit, totaling 223,025 hundred million yen in net sales. Operating income is 14,944 hundred million yen, ordinary income is 13,750 hundred million yen, and net income attributable to owners of the parent is 8,941 hundred million yen. On the cost side, details of selling, general and administrative expenses are provided, with segment contributions to profit also listed.

Section 2 Heading

Financial position synopsis: the balance sheet with assets, liabilities, and net assets is presented, listing assets such as cash and deposits, notes receivable, accounts receivable, and goods and products. In the liabilities section, current and noncurrent liabilities are shown, with total assets and total liabilities contrasted. The quarterly consolidated balance sheet components and notes on capital movements are provided, offering material insights into financial health.

Net Sales Trend

Operating Income Trend

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Kaneka

Company overview · Stock price · Financial data · All IR

View company page →